Delivery Order SPE2DB22D2005-SPE2DB25FJSJ6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,921.88 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. This non-set-aside, competitively awarded contract utilized firm fixed pricing and was completed on August 13, 2025, one day after the award date of August 12, 2025. The place of performance is listed as the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $9,392.34 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL formulations. This competitively awarded, firm fixed-price contract was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting the open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulation, valued at $8,366.58 with a firm fixed price contract structure. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-set-aside, competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations, valued at $30,494.73. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and represents a non-set-aside competitive award. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL formulations. This competitively awarded, non-set-aside delivery order carries a ceiling value of $32,930.62 under firm fixed-price terms, with an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $35,602.74 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL format. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of August 14, 2025. The delivery order was issued on August 13, 2025, as a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 ml vials, with a ceiling value of $2,819.97. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and no set-aside designation was applied. The order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $41,688.44 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml). This firm fixed-price delivery order is set to be completed by August 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded, non-set-aside contract for pharmaceutical products supporting federal medical procurement needs. This...
- The Defense Logistics Agency awarded a $17,428.58 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL formulation. This competitively awarded, firm fixed-price contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. The delivery order is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $33,160.61 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL), with completion targeted for August 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing contract vehicle. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate office and...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJSJ6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,983.84 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens (3 mL) with a firm fixed price contract type. The award was made on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. Performance will take place at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Pennsylvania that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems, with an established track record of fulfilling diverse pharmaceutical supply requirements through the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 8/22/25 |